Monday, January 17, 2022, 1:01 p.m.
“IMH” fights against COVID Focusing on increasing income, broker recommends buying, target 28 baht
Intermedical Care and Lab Hospital “IMH” sends “ONSITE” ATK to strengthen the army to fight the battle “Omicron”, confident to push the revenue of the year 65 through 1,200 million baht, send Sigma to prepare to count down, wait for good news upside, close M&A deals soon In this regard, Yuanta Brokerage walks in the game to recommend buying. Order to adjust the target to touch 28 baht
Dr. Sittiwat Kamkangwong, Chief Executive Officer of Inter Medical Care and Lab Hospital Public Company Limited (IMH), revealed that since the beginning of January 65, the IMH group has been providing treatment for patients who haveget infected with covid that tends to increase from the spread of COVID New mutant “Comikron” in both testing for covids and treatment of covid patientsRecently, IMH has launched a new COVID-19 test kit “ONSITE”ATK which is sensitive (Sensitivity) to detect the COVID-19 virus. which will be a medical innovationA new model that helps in detecting infectious diseasescurrent epidemic effectively another brand
The widespread outbreak of “Omicron” in this round will result in coronavirus patients. in the public health system of Thailand can increase by more than 10,000 – 30,000 people per day from the assessmentof the Ministry of Public Health which may cause the patient bed not enough and has serious complications for patients with 7 risk groups, such as diabetes, cancer, heart disease, obesity, etc.
“IMH will start to open for covid testing.The new type “ONSITE” ATK and issuing certificates of Covid results for both walk-in customers and provide onsite inspection services to the company/factory. to give confidence to customersfor returning to work and for travel which is a way to make thenormal life safely and Be confident in yourself and those who blameThe surrounding environment as well,” said Dr. Sittiwat.
while Prachapat Hospital (subsidiary company) is ready to deal withNumber of patients who will come to treat covid both via direct contact at Prachapat Hospital and passed the “ONSITE” ATK examination by the medical personnel unit of Intermed Hospital (parent company), which in the past, Prachapat Hospital has experience in managing covid patients in 2021 as well. good, as well as have prepared a waiting center in the areaRestoration of 200 field beds and 9 negative pressure beds which is managed by Prachapat Hospital already supported
In addition, Dr. Sittiwat also referred to the overall picture of the IMH group for the year 2022 that the company expects total revenue to reach a trend.The level exceeds 1,200 million baht, which is considered a new high level. as well as being able to manage the costThe total amount was lower than last year.Past due to the synergy between Intermed Hospital (parent company) and Prachapat Hospital (subsidiary company), which does not include business expansion dealsnew hospital which is currently under negotiation It is expected to be clear within the periodThis quarter 1/2565
In terms of Yuanta Securities (Thailand) Co., Ltd., assessed that IMH’s business overview in the past that IMH has benefited. from the infection and treatment of covidbecause it is a hospital withComprehensive treatment Including the result of mergers and acquisitions (M&A), resulting from the assessment thatlast year’s profits increasedIn the year 2022, the IMH group still has plans to expand and expand the business.continuous business Therefore, from the supporting factorsAs a result, Yuanta Securities recommends a buy. by giving a reasonable price of 28 baht
